Avid Bioservices Inc (CDMO)

[pphmtoolong]

Sunrise enrollment guess. Assuming at most 120 still to enroll, then about 480 patients are in the trial. That's 240 patients around the world with Bavi in their bloodstreams.

I'm sure we all wish them well.

My additional guess is we will see a first look-in in mid-October. Can't say what Peregrine will be in a position to share with us. Hope it's more than enrollment continues on track and no unexpected adverse reactions reported. That would be bad news for the share price IMO. Dearly hope they can throw us some kind of bone.

GTLA, Paul